Global X S&P Biotech ETF (ASX:CURE)
Australia · Delayed Price · Currency is AUD 76.90
-0.47 (-0.61%)
Sep 1, 2026, 2:45 PM AEST
ASX:CURE Holdings Information
ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Twist Bioscience stock at 1.73%, Oruka Therapeutics at 1.57%, Apogee Therapeutics at 1.53%, Praxis Precision Medicines at 1.51%, and Dianthus Therapeutics at 1.38%.
Total Holdings
10
Top 10 Percentage
14.51%
Asset Class
Equity
ETF Category
Health Care
Assets
51.67M
PE Ratio
n/a
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TWST | Twist Bioscience Corporation | 1.73% |
| 2 | ORKA | Oruka Therapeutics, Inc. | 1.57% |
| 3 | APGE | Apogee Therapeutics, Inc. | 1.53% |
| 4 | PRAX | Praxis Precision Medicines, Inc. | 1.51% |
| 5 | DNTH | Dianthus Therapeutics, Inc. | 1.38% |
| 6 | NTRA | Natera, Inc. | 1.37% |
| 7 | KYMR | Kymera Therapeutics, Inc. | 1.37% |
| 8 | HALO | Halozyme Therapeutics, Inc. | 1.35% |
| 9 | INSM | Insmed Incorporated | 1.35% |
| 10 | PTGX | Protagonist Therapeutics, Inc. | 1.35% |
As of Aug 12, 2026